CODX Net Debt from 2010 to 2024

CODX Stock

USD 1.01 0.05 4.72%

Co Diagnostics Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt will likely drop to about -12.5 M in 2024. Net Debt is the total debt of Co Diagnostics minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2016-12-31

Previous Quarter

-11.3 M

Current Value

-8.4 M

Quarterly Volatility

32.2 M

Covid

Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.

Check out the analysis of Co Diagnostics Correlation against competitors.

For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Net Debt Growth Pattern

Below is the plot of the Net Debt of Co Diagnostics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Co Diagnostics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

CODX Net Debt Regression Statistics

	Arithmetic Mean	(11,591,090)
	Coefficient Of Variation	(212.82)
	Mean Deviation	16,093,776
	Median	958,335
	Standard Deviation	24,668,669
	Sample Variance	608.5T
	Range	91M
	R-Value	(0.51)
	Mean Square Error	485.9T
	R-Squared	0.26
	Significance	0.05
	Slope	(2,804,738)
	Total Sum of Squares	8519.6T

CODX Net Debt History

	2024	-12.5 M
	2023	-11.9 M
	2022	-22.6 M
	2021	-88.6 M
	2020	-43 M
	2019	-893.1 K
	2018	958.3 K

Other Fundumenentals of Co Diagnostics

Net Debt To E B I T D A

Co Diagnostics Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Long Term Debt Total	Short Long Term Debt	Short Term Debt	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		1.0	0.89	0.89	0.69	0.84	0.9	0.99	-0.24	0.81	-0.86	0.79	-0.54	0.43	0.42	0.72	0.48	0.99	0.42	0.98	0.93
Total Stockholder Equity	1.0		0.89	0.89	0.7	0.84	0.87	0.99	-0.23	0.82	-0.84	0.77	-0.54	0.42	0.4	0.75	0.47	0.99	0.45	0.99	0.94
Net Tangible Assets	0.89	0.89		0.71	0.93	0.98	0.73	0.88	-0.28	0.97	-0.66	0.55	-0.71	0.47	0.34	0.94	0.43	0.93	0.57	0.91	0.98
Retained Earnings	0.89	0.89	0.71		0.48	0.59	0.82	0.9	0.02	0.6	-0.84	0.82	-0.19	0.14	0.23	0.53	0.22	0.89	0.24	0.91	0.73
Accounts Payable	0.69	0.7	0.93	0.48		0.94	0.5	0.67	-0.23	0.97	-0.37	0.23	-0.71	0.41	0.12	0.96	0.27	0.75	0.52	0.72	0.87
Capital Surpluse	0.84	0.84	0.98	0.59	0.94		0.68	0.82	-0.38	0.98	-0.57	0.44	-0.8	0.55	0.35	0.93	0.48	0.88	0.53	0.85	0.96
Total Liab	0.9	0.87	0.73	0.82	0.5	0.68		0.87	-0.29	0.64	-0.9	0.84	-0.48	0.45	0.5	0.47	0.49	0.87	0.14	0.85	0.75
Total Current Assets	0.99	0.99	0.88	0.9	0.67	0.82	0.87		-0.25	0.78	-0.88	0.82	-0.53	0.44	0.46	0.73	0.51	0.99	0.5	0.99	0.93
Common Stock	-0.24	-0.23	-0.28	0.02	-0.23	-0.38	-0.29	-0.25		-0.3	0.21	-0.17	0.72	-0.78	-0.51	-0.27	-0.49	-0.24	-0.31	-0.24	-0.3
Property Plant Equipment	0.81	0.82	0.97	0.6	0.97	0.98	0.64	0.78	-0.3		-0.5	0.36	-0.74	0.48	0.2	0.94	0.33	0.86	0.46	0.82	0.94
Net Debt	-0.86	-0.84	-0.66	-0.84	-0.37	-0.57	-0.9	-0.88	0.21	-0.5		-0.98	0.36	-0.32	-0.65	-0.42	-0.59	-0.83	-0.34	-0.85	-0.7
Net Receivables	0.79	0.77	0.55	0.82	0.23	0.44	0.84	0.82	-0.17	0.36	-0.98		-0.24	0.26	0.65	0.31	0.58	0.75	0.35	0.79	0.6
Long Term Debt Total	-0.54	-0.54	-0.71	-0.19	-0.71	-0.8	-0.48	-0.53	0.72	-0.74	0.36	-0.24		-0.89	-0.54	-0.71	-0.57	-0.56	-0.52	-0.54	-0.69
Short Long Term Debt	0.43	0.42	0.47	0.14	0.41	0.55	0.45	0.44	-0.78	0.48	-0.32	0.26	-0.89		0.59	0.45	0.5	0.43	0.4	0.42	0.5
Short Term Debt	0.42	0.4	0.34	0.23	0.12	0.35	0.5	0.46	-0.51	0.2	-0.65	0.65	-0.54	0.59		0.2	0.82	0.39	0.49	0.42	0.41
Current Deferred Revenue	0.72	0.75	0.94	0.53	0.96	0.93	0.47	0.73	-0.27	0.94	-0.42	0.31	-0.71	0.45	0.2		0.32	0.79	0.69	0.78	0.91
Deferred Long Term Liab	0.48	0.47	0.43	0.22	0.27	0.48	0.49	0.51	-0.49	0.33	-0.59	0.58	-0.57	0.5	0.82	0.32		0.46	0.57	0.47	0.49
Net Invested Capital	0.99	0.99	0.93	0.89	0.75	0.88	0.87	0.99	-0.24	0.86	-0.83	0.75	-0.56	0.43	0.39	0.79	0.46		0.45	0.99	0.95
Long Term Investments	0.42	0.45	0.57	0.24	0.52	0.53	0.14	0.5	-0.31	0.46	-0.34	0.35	-0.52	0.4	0.49	0.69	0.57	0.45		0.51	0.6
Net Working Capital	0.98	0.99	0.91	0.91	0.72	0.85	0.85	0.99	-0.24	0.82	-0.85	0.79	-0.54	0.42	0.42	0.78	0.47	0.99	0.51		0.94
Capital Stock	0.93	0.94	0.98	0.73	0.87	0.96	0.75	0.93	-0.3	0.94	-0.7	0.6	-0.69	0.5	0.41	0.91	0.49	0.95	0.6	0.94

Click cells to compare fundamentals

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-11.9 M	-12.5 M
Net Debt To EBITDA	0.29	0.30

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CODX Net Debt from 2010 to 2024

Latest Co Diagnostics' Net Debt Growth Pattern

CODX Net Debt Regression Statistics

CODX Net Debt History

Other Fundumenentals of Co Diagnostics

Co Diagnostics Net Debt component correlations

About Co Diagnostics Financial Statements

Also Currently Popular

Additional Tools for CODX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY